Market Overview 2023-2028:
The global medical plastics market size reached US$ 25.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 38.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Medical plastics refer to various polymeric materials manufactured specifically for healthcare applications. They are commonly used for tamper-proof caps, vials, beakers, inhalations masks, bedpans, intravenous (IV) tubes, pill casings, surgical instruments, prosthetics and catheters. Some of the commonly used variants include silicon, synthetic rubber, polymer blends, high performance and engineering plastics. They are produced using hypoallergenic, biocompatible, medical-grade polypropylene and polycarbonate materials. They are shatter-proof, non-permeable, temperature, chemical and corrosion-resistant and can have frequent sterilization cycles. Medical plastics can also be used to transport biohazardous materials as they have antimicrobial surfaces and can aid in preventing the spread of pathogens.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Global Medical Plastics Market Trends:
Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for single-use medical plastics and consumables in the healthcare centers. Hospitals, diagnostic centers and clinics are extensively using thermal scanners, ventilators, gloves, respirators and masks for the treatment of the patients. Additionally, various product innovations, such as the development of medical plastics with enhanced biocompatibility, are acting as other growth-inducing factors. These novel variants are more cost-effective and are used in targeted drug delivery systems for the controlled release of drugs in complex parts of the brain and to treat various degenerative diseases. Other factors, including extensive improvements in the healthcare infrastructure, especially in the developing economies, along with the rising geriatric population, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical plastics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on material and application.
Breakup by Material:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Polyvinyl Chloride (PVC)
- Polypropylene (PP)
- Engineering Plastics
- Polyethylene (PE)
- Polystyrene (PS)
- Silicones
- Others
Breakup by Application:
- Disposables
- Drug Delivery Devices
- Diagnostic Instruments
- Catheters
- Surgical Instruments
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.) and Trinseo PLC.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Material, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.) and Trinseo PLC |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |